CDER Director Cavazzoni’s departure paves way for Trump to reshape FDA

The resignation of Patrizia Cavazzoni as director of FDA’s Center for Drug Evaluation and Research, announced Friday, along with the recent and anticipated departures of other senior leaders, offers the incoming Trump administration a powerful opportunity to reshape the agency – and raises concerns about institutional stability and the integrity of public health oversight.

Cavazzoni’s announcement follows the decision by Jeff Shuren to step down as director of the Center for Devices and Radiological Health. ...